Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PROPAFENONE HCL ER 325 MG CAP

propafenone hydrochloride
$0.4758per EA

Strength

325 mg/1

Manufacturer

Glenmark Pharmaceuticals Inc., USA

NDC

68462040960

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PROPAFENONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205268

On Market Since

9/8/2017

Pharmacological Classes

Antiarrhythmic

Price History

1W

0.0%

1M

+3.0%

3M

+8.5%

6M

-21.7%

1Y

-33.8%

3Y

-65.8%

5Y

-64.7%

All

-91.5%

Generic Alternatives

2 alternatives • Same active ingredient

PROPAFENONE HCL ER 325 MG CAP
Generic
16714082601•NorthStar Rx LLC
$0.4758
PROPAFENONE HCL ER 325 MG CAP
Generic
64380018502•Strides Pharma Inc.
$0.4758

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0283
per GM
LIDOCAINE HCL 1% VIAL
Generic
00409427602•Hospira Inc.
$0.0397
per ML
GNP LIDOCAINE HCL 4% CREAM
Generic
46122061410•AmerisourceBergen
$0.0514
per GM
LIDOCAINE HCL 4% CREAM
Generic
70000009801•Cardinal Health
$0.0514
per GM
LIDOCAINE HCL 2% VIAL
Generic
00409427702•Hospira Inc.
$0.0569
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016300•Eugia US LLC
$0.0689
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016330•Eugia US LLC
$0.0689
per ML
SOTALOL 80 MG TABLET
Generic
00093106101•Teva Pharmaceuticals USA Inc.
$0.0694
per EA
SOTALOL 80 MG TABLET
Generic
00904714361•Major Pharmaceuticals
$0.0694
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy